Centar Za Kojno-Venericheski Zabolyavania EOOD
- Address
- Ulitsa Georgi Izmirliev 8, 1404 Sofia, Bulgaria
Centar Za Kojno-Venericheski Zabolyavania EOOD - Dermatology Research Center
Centar Za Kojno-Venericheski Zabolyavania EOOD is a specialized dermatology research center with expertise in conducting clinical trials for chronic inflammatory skin conditions. The center demonstrates significant capability in dermatological research, particularly focusing on advanced therapeutic interventions for complex skin diseases requiring long-term management and innovative treatment approaches.
- Moderate to Severe Plaque Psoriasis clinical trials
- Novel biologic and systemic therapy evaluation (ESK-001)
- Long-term safety and efficacy extension studies
The facility participates in multi-phase clinical trial programs, including both pivotal Phase 3 efficacy studies and extension trials designed to assess durability of response and long-term safety profiles. Their involvement in placebo-controlled and active comparator studies demonstrates commitment to rigorous research methodologies in evaluating emerging psoriasis treatments and advancing therapeutic options for patients with chronic inflammatory dermatological conditions.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Alumis Inc.2trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 476 other sites in Bulgaria
Therapeutic Area Benchmark — Bulgaria
Select a therapeutic area to compare against other sites in Bulgaria.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Bulgaria
Market Share
Country: Bulgaria
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Centar Za Kojno-Venericheski Zabolyavania EOOD
lock Showing 1 of 2 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Long-term Safety, Efficacy, and Response Durability of Envudeucitinib in Moderate to Severe Plaque Psoriasis: An Extension Study | Alumis Inc. | Phase III | Not Recruiting | Jun 2025 | — |
IMP list
lock Showing 1 of 2 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Envudeucitinib | 2 | Unknown | 2025-01-16 | 2025-06-13 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.